2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      HTA challenges for appraising rare disease interventions viewed through the lens of an institutional multidimensional value framework.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Evaluating rare disease interventions poses challenges for HTA agencies, including uncertainties and ethical issues and tensions. INESSS has recently adopted a Statement of Principles and Ethical Foundations which proposes a multidimensional approach to value appraisal as well as five principles to frame the evaluation process.

          Related collections

          Author and article information

          Journal
          Expert Rev Pharmacoecon Outcomes Res
          Expert review of pharmacoeconomics & outcomes research
          Informa UK Limited
          1744-8379
          1473-7167
          Feb 2023
          : 23
          : 2
          Affiliations
          [1 ] Bureau - Méthodologies et éthique, Institut national d'excellence en santé et en services sociaux (INESSS), 2021 Avenue Union, bureau 1200; Montréal H3A 2S9, Quebec, Canada.
          [2 ] School of Public Health, Department of Management, Evaluation and Health Policy, Université de Montréal; 7101, avenue du Parc, 3e étage H3N 1X9 Montréal, Quebec, Canada.
          [3 ] School of Public Health, Department of Social and Preventive Medicine, Université de Montréal, 7101avenue du Parc, 3e étage H3N 1X9 Montréal, Quebec, Canada.
          [4 ] Institut national d'excellence en santé et en services sociaux (INESSS), 2021 Avenue Union, bureau 1200; Montréal H3A 2S9, Québec, Canada.
          Article
          10.1080/14737167.2023.2161513
          36542763
          23547700-aae5-4540-8091-1ba2a1f10d65
          History

          rare diseases,multidimensional,HTA,Challenge,value framework,value appraisal

          Comments

          Comment on this article